| Literature DB >> 24509417 |
Aitor Larrañaga1, Andrée-Anne Guay-Bégin1, Pascale Chevallier2, Gad Sabbatier2, Jorge Fernández3, Gaétan Laroche2, Jose-Ramon Sarasua3.
Abstract
Thermoplastic biodegradable polymers displaying elastomeric behavior and mechanical consistency are greatly appreciated for the regeneration of soft tissues and for various medical devices. However, while the selection of a suitable base material is determined by mechanical and biodegradation considerations, it is the surface properties of the biomaterial that are responsible for the biological response. In order to improve the interaction with cells and modulate their behavior, biologically active molecules can be incorporated onto the surface of the material. With this aim, the surface of a lactide and caprolactone based biodegradable elastomeric terpolymer was modified in two stages. First, the biodegradable polymer surface was aminated by atmospheric pressure plasma treatment and second a crosslinker was grafted in order to covalently bind the biomolecule. In this study, albumin was used as a model protein. According to X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM), albumin was efficiently immobilized on the surface of the terpolymer, the degree of albumin surface coverage (ΓBSA) reached ~35%. Moreover, gel permeation chromatography (GPC) studies showed that the hydrolytic degradation kinetic of the synthesized polymer was slightly delayed when albumin was grafted. However, the degradation process in the bulk of the material was unaffected, as demonstrated by Fourier transform infrared (FTIR) analyses. Furthermore, XPS analyses showed that the protein was still present on the surface after 28 days of degradation, meaning that the surface modification was stable, and that there had been enough time for the biological environment to interact with the modified material.Entities:
Keywords: albumin; grafting; hydrolytic degradation; poly(lactide/ε-caprolactone); surface modification; terpolymer
Mesh:
Substances:
Year: 2014 PMID: 24509417 PMCID: PMC4014455 DOI: 10.4161/biom.27979
Source DB: PubMed Journal: Biomatter ISSN: 2159-2527
Table 1. Main characteristics of the lactide and caprolactone based terpolymer
| Structural properties | Mw (x103) | 101.6 g/mol | |
| Dispersity ( | 2.3 | ||
| %L-lactide | 66.9% | ||
| Composition | %D-lactide | 17.4% | |
| %ε-caprolactone | 15.7% | ||
| Microstructural magnitudes | lLA | 6.68 | |
| lL-LA3 | 3.18 | ||
| lD-LA3 | 1.27 | ||
| lCL | 1.25 | ||
| R | 0.95 | ||
| Physical properties | Tg | ~34°C | |
| Mechanical properties | Secant modulus (at 2%) | 21°C | 763.2 ± 68.3 MPa |
| 37°C | 10.5 ± 1.4 MPa | ||
| Yield strength | 21°C | 21.1 ± 1.8 MPa | |
| 37°C4 | 0.7 ± 0.1 MPa | ||
| Tensile strength | 21°C5 | 17.1 ± 0.9 MPa | |
| 37°C6 | 1.6 ± 0.1 MPa | ||
| Elongation at break | 21°C | 354 ± 35% | |
| 37°C | >300% | ||
| Strain recovery | 21°C | 79 ± 4% |
1 Calculated from 1H NMR spectra. Because of the impossibility of offering the exact L-LA and D-LA molar content (indistinguishable in the NMR spectrum), approximate values are given under the assumption that the reactivity of both L-LA and D-LA are the same. 2lLA and lCL are the LA and CL number average sequence lengths obtained from 1H NMR. These values are compared with the Bernoullian random number-average sequence lengths (lLA = 1/CL and lCL = 1/LA), obtaining the randomness character value (R). 3lL-lA and lD-LA are the L-LA and D-LA approximate values of number average sequence lengths under the assumption that the reactivity of both L-LA and D-LA are the same. 4Offset Yield Strength was calculated at a 10% of strain using the secant modulus at 2% as elastic modulus (E) for the material at 37 °C since no yield point was observed in the stress-strain plot. 5The tensile strength was determined as ultimate stress value (σu). 6The tensile strength was determined as the stress value at 300% of deformation. 7At 37 °C, the maximum permitted distance between clamps corresponds to a sample deformation of 300%.

Figure 1. Synthesis of the PLCL (above) and schematic representation of the covalent grafting of BSA on its surface (below).
Table 2. Surface compositions determined by XPS survey analyses and contact angle (CA) values after each surface modification step
| | | | | | | |
|---|---|---|---|---|---|---|
| 61.5 ± 0.7 | 38.5 ± 0.7 | - | 1.6 | - | 73 ± 2 | |
| 67.7 ± 0.9 | 28.8 ± 1.9 | 3.5 ± 1.0 | 2.4 | 0.4 ± 0.1 | 29 ± 2 | |
| 62.0 ± 0.5 | 37.8 ± 0.4 | 0.2 ± 0.1 | 1.6 | - | - | |
| 65.8 ± 1.2 | 29.8 ± 1.3 | 4.4 ± 0.6 | 2.2 | - | 52 ± 2 |

Figure 2. High-resolution C 1s spectra of (A) pristine PLCL, (B) plasma treated PLCL, (C) sulfo-SMPB grafted PLCL and (D) albumin grafted PLCL.

Figure 3. AFM images (20 × 20 µm2) of pristine PLCL (top-left), plasma treated PLCL (top-right), albumin-grafted PLCL (bottom-left) and albumin-grafted PLCL treated with Image J software (bottom-right). In the image treated by Image J, white spots correspond to albumin deposits and where used to estimate albumin surface coverage.

Figure 4. DSC curves of the 1st scans of PLCL at different degradation times.

Figure 5. Evolution of Mw at different times of degradation for PLCL (■), P-PLCL (○) and BSA-PLCL (▲) (left axis) and gravimetric data for PLCL (■) and P-PLCL (○) (right axis).

Figure 6. FTIR spectra for PLCL at different degradation times.

Figure 7. COO-/C = O ratio for PLCL (―○—) and BSA-PLCL (―■—) samples (left axis) and %N detected by XPS on the surface of BSA-PLCL sample during degradation (- - ▼ - -) (right axis).